Haemonetics
HAE
$77.42
Share price
1.76%
Change (1 day)
30.31%
Change (1 year)
Categories
Market capitalization of Haemonetics (HAE)
Market cap: $3.90 Billion
As of March 2023 Haemonetics has a market cap of $3.90 Billion. This makes Haemonetics the world's 2713th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Haemonetics from 2001 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $3.90 B | -1.88% |
| 2022 | $3.98 B | 46.84% |
| 2021 | $2.71 B | -55.05% |
| 2020 | $6.02 B | 4.14% |
| 2019 | $5.78 B | 13.49% |
| 2018 | $5.10 B | 66.31% |
| 2017 | $3.06 B | 47.72% |
| 2016 | $2.07 B | 26.8% |
| 2015 | $1.63 B | -15% |
| 2014 | $1.92 B | -11.86% |
| 2013 | $2.18 B | 3.66% |
| 2012 | $2.10 B | 37.9% |
| 2011 | $1.52 B | -2.18% |
| 2010 | $1.56 B | 12.84% |
| 2009 | $1.38 B | -3.57% |
| 2008 | $1.43 B | -11.01% |
| 2007 | $1.61 B | 35.76% |
| 2006 | $1.18 B | -8.49% |
| 2005 | $1.29 B | 38.66% |
| 2004 | $0.93 B | 57.6% |
| 2003 | $0.59 B | 14.35% |
| 2002 | $0.52 B | -42.09% |
| 2001 | $0.89 B |
End of Day market cap according to different sources
On Mar 25th, 2023 the market cap of Haemonetics was reported to be:
$3.90 Billion
$3.90 Billion
$3.91 Billion
$3.90 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $476.24 B | 12,093.72% | 🇺🇸 USA |
 Medtronic MDT | $105.59 B | 2,603.66% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $215.17 B | 5,409.21% | 🇺🇸 USA |
 Baxter BAX | $19.83 B | 407.77% | 🇺🇸 USA |
 Becton Dickinson BDX | $68.27 B | 1,648.20% | 🇺🇸 USA |
 Stryker Corporation SYK | $104.81 B | 2,583.78% | 🇺🇸 USA |
 PerkinElmer
PKI | $16.12 B | 312.93% | 🇺🇸 USA |
 Cerus CERS | $0.51 B | -86.81% | 🇺🇸 USA |